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Risk factors for dementia in the ninth
decade of life and beyond: a study of
the Lothian birth cohort 1921
Ruth A. Sibbett1,2*, Tom C. Russ1,2,4, Ian J. Deary1,2,3 and John M. Starr1,2
Abstract
Background: With increasing numbers of people surviving beyond eighty years, this section of the population
demands attention to reduce the impact of dementia. In order to develop effective preventative strategies, it is
essential to understand age-specific risk factor profiles for dementia: do risk factors for dementia in those in their
sixties and seventies persist into oldest age? The aims of this study were to determine incident dementia and to
investigate the risk profile for dementia from age 79 to 95 years in a well-characterised cohort.
Methods: Participants underwent intelligence testing at age 11 and were followed-up from at 79 years of age.
Variables included: age, sex, age 11 IQ, APOE ɛ4, education, diabetes, hypertension, statin use, physical activity at
leisure and in occupation, symptoms of depression, height, number of teeth, body mass index, blood pressure,
cholesterol and HbA1c. Dementia cases were ascertained from death certificates, electronic patient records and
clinical reviews. Logistic regression analysis determined the degree of risk for dementia associated with each
variable. Analyses were completed both with and without the physical activity variables due to the significant
number of missing data for these variables.
Results: Of the eligible cohort, n = 410 participants remained dementia-free and n = 110 had developed probable
dementia. When logistic regression analyses contained all variables, complete data was available for n = 234 (n = 48
with dementia). Results demonstrated that positive APOE ɛ4 carrier status (OR: 2.15, 95% CI: 1.04, 4.42) and greater
lifetime physical activity (OR: 1.14, 95% CI: 1.02, 1.28) increased the risk for dementia. A reduction in risk for
dementia was seen for hypertension (OR: 0.47, 95% CI: 0.23, 0.98). When physical activity variables were excluded,
the number with complete data increased to n = 377 (n = 80 with dementia). APOE ɛ4 remained significant
(OR: 2.37; 95% CI: 1.37, 4.07), as did hypertension (OR: 0.55; 95% CI: 0.32, 0.93).
Conclusions: Dementia incidence was consistent with expected rates. The risk profile for dementia in this cohort of
participants aged 79–95 confirmed previous findings that risk factors differ for those over 79 years. Further evidence
is recommended in order that the risk profile for this age group can be accurately determined.
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Background
Without clear means of prevention or cure, dementia is
recognised to be one of the greatest public health chal-
lenges facing the ageing global population. Dementia
rates are known to increase exponentially with age, from
5.5 per 1000 person-years in those aged 70–74, to 30.5
per 1000 person-years in those aged 80–84 [1]. With
increasing numbers of people surviving into the ninth
decade of life and beyond [2], this section of the popula-
tion demands attention in order to reduce the impact of
dementia [3]. Despite studies such as the 90+ Study [4].
(North America) and the Monzino 80-plus Study [5].
(Italy) the oldest in the population remain less well
represented in dementia research.
In order to develop effective preventative strategies
for dementia and ensure that these are directed
appropriately, it is essential to identify potentially
modifiable risk factors and understand whether these
persist into oldest age. Significant modifiable risk
factors for dementia demonstrated by replication
within the literature include: diabetes [6], hyperten-
sion [7], hypercholesterolaemia [8], depression [9],
smoking [10, 11], obesity [11]. and physical inactivity
[11–13]. Previous studies have proposed that the risk
factor profile for dementia changes with age, but the
evidence is not conclusive [14, 15].
The present study draws on prospectively collected
longitudinal data from the Lothian Birth Cohort 1921
(LBC1921). Participants were predominantly cognitively
normal at baseline (aged 79 years) and underwent de-
tailed follow-up to age 95 years. As a result, this study
can add further evidence to the literature regarding risk
factors for dementia in the oldest-old. Most participants
in this cohort had also taken part in childhood
intelligence testing at age 11 years. This is an unusual
and valuable feature of the data for a study cohort of the
oldest-old, given that lower childhood IQ has been
shown to be a putative risk factor for dementia [16]. and
is associated with several modifiable risk factors [17–19].
Dementia ascertainment had not previously been per-
formed in LBC1921 and, although a number of partici-
pants would have developed dementia during the study
period, there had not been any clear means of identifying
all such participants. Mini-Mental State Examination
(MMSE) [20]. was performed at each wave of follow-up
and a small number were seen for clinical review follow-
ing concerns raised regarding their cognitive function.
Some participants self-reported a new diagnosis of
dementia. This would have identified only a proportion
of cases. There was no previous follow-up regarding
dementia ascertainment for those who had died or left
the study. Given the likelihood that participants with in-
cident dementia were less likely to attend for follow-up,
death records would be a valuable source data for
dementia ascertainment, particularly where a diagnosis
of dementia failed to be recorded in the secondary care
records.
The primary aims of this study were: i) to determine
cases of incident dementia within the LBC1921 study
cohort from age 79–95, and ii) to investigate whether
recognised modifiable risk factors for dementia (diabetes,
hypertension, hypercholesterolaemia, depression, smok-
ing, physical inactivity, obesity) remained risk factors for
dementia in the ninth decade and beyond. These modifi-
able risk factors were considered together with key non-
modifiable factors including; age 11 IQ, APOE ɛ4 status,
and measures associated with socio-economic status.
The present study primarily drew on existing data
for dementia ascertainment. Given the variability in
methodology for using routinely collected data in the
literature, we aimed to quantify the effectiveness of
our dementia ascertainment method as a secondary
outcome.
Methods
Study population
The LBC1921 is described in detail elsewhere [21], and
is outlined briefly here. Almost all Scottish school pupils
born in 1921 had their general intelligence tested at
age ~ 11 years as part of the Scottish Mental Survey
1932 [22]. Beginning in 1999, the LBC1921 was designed
in order to follow up some of the same participants in
later life with the primary aim of investigating non-
pathological cognitive ageing [23]. The LBC1921 in-
cludes 550 participants recruited from the Lothian area
of Scotland, as relatively healthy, community-dwelling
volunteers, most of whom had taken part in intelligence
testing in 1932. Lothian is an area in southeast Scotland
in which the largest settlement is the city of Edinburgh.
Participants underwent the first wave of testing at ap-
proximately 79 years of age. Those participants surviving
and continuing to consent to inclusion in the study were
re-tested at regular intervals, at mean ages of about 83,
87, 90 and 92 years of age. The data were collected by
questionnaire and one-to-one testing and included mea-
sures of socio-demographic, psychological, cognitive,
medical, physiological, and genetic factors. Those partic-
ipants self-reporting a history of dementia or scoring less
than 24 on the MMSE at baseline were excluded from
our study (n = 11), as were those who were missing
baseline MMSE data (n = 2). Deaths were ascertained
prospectively, with records for participants supplied by
the General Registrar’s Office, Scotland [24]. Ethical
approval was provided by the Lothian Research Ethics
Committee (test waves 1–3) and the Scotland A Re-
search Ethics Committee (test waves 4–5). Participants
attending from wave 4 provided written consent for data
linkage and access to health records.
Sibbett et al. BMC Psychiatry  (2017) 17:205 Page 2 of 10
Dementia ascertainment
Surviving participants who continued to take part in the
LBC1921 study were seen for routine follow-up as de-
scribed previously. Follow-up for the purposes of detect-
ing dementia diagnoses included the retrospective
collection of evidence from the sources described below,
from enrolment to age 95 years. Dementia cases were
determined at a final consensus meeting on 15th
December 2016. Death records for deceased participants
were examined for evidence of cognitive impairment or
dementia. Data from death records were collected from
those available by 30th June 2016. For consenting partic-
ipants, data were collected from medical and psychiatric
electronic patient records for services in Lothian. Pa-
tients were located in the system using their Community
Health Index (CHI) number, a unique number given to
each patient within Scotland, recorded at every health
service contact. Each hospital record accessed was read
in full and examined for evidence of dementia or cogni-
tive impairment since enrolment in the study. This in-
cluded gathering both recorded confirmed diagnoses
and evidence for diagnoses. Until 2014, general and
psychiatric records were held on separate systems (Trak
and PIMS respectively), but all records were subse-
quently incorporated into the Trak system. The final
date for data collection from this source was 16th May
2016. For 26 participants, additional information was
available as a result of clinical assessments undertaken
by the authors (JMS or TCR) in the NHS or research
setting. In the research setting, assessments were under-
taken when impairment or decline was noted during the
routine LBC1921 testing, or when a new diagnosis of
dementia was self-reported. Data from these sources
were collected until the consensus date.
Each case with evidence of cognitive impairment or
dementia was considered at a consensus meeting (RAS,
TCR, JMS) which included both a geriatrician and a
psychiatrist. The meeting agreed upon whether the
evidence supported a diagnosis of dementia and deter-
mined the subtype of dementia. Depending on the
strength of the evidence, the diagnosis and subtype were
deemed either ‘probable’ or ‘possible’. The criteria for
probable and possible diagnoses utilised by the consen-
sus are shown in Table 1. Any disagreement on diagnosis
was resolved through discussion.
Dementia subtype diagnoses were made on a similar
basis. Any dementia case with insufficient evidence to
make a subtype diagnosis was classified as ‘unknown’
subtype. In order to minimise the risk of misclassifica-
tion bias, probable dementia cases would be used as our
primary outcome and possible cases would be excluded
from the analyses. We would however repeat our
analyses including possible dementia cases and include
the results as supplementary information.
Variables
Modifiable risk factors assessed in the present study
were identified by matching those consistently reported
in the literature (diabetes, hypertension, depression,
hypercholesterolaemia, smoking, obesity, and physical
inactivity) [12]. with data collected at LBC1921 test
waves. We also included the following variables: age,
sex, APOE ɛ4 status, age 11 IQ, number of teeth (as a
post-retirement measure of socio-economic status [25]),
height, and years in full-time, formal education. The full
list of included variables is detailed in Additional file 1:
Table S1.
Age at baseline was calculated according to the num-
ber of days between birth date and date attending wave
1 testing. The presence of at least one APOE ɛ4 allele
was determined using genomic DNA isolated from ven-
ous blood [26]. Venous blood was also used to measure
total serum cholesterol and HbA1c [21]. Any previous
history of diabetes or hypertension, years in formal edu-
cation, use of statins, and smoking status (previous,
current or never) were self-reported by participants [26].
Body mass index (BMI) was calculated from height and
weight, measured using a SECA stadiometer and digital
SECA scales, respectively [27]. A trained research nurse
measured sitting blood pressures (systolic and diastolic)
using an Omron 705IT monitor [24]. Remaining teeth
were counted during the general physical assessment
[25]. Symptoms of depression were evaluated using the
self-reported Hospital Anxiety and Depression Scale
[28]. (HADS) at wave 1 [29]. Only the scores for the
depression sub-scale were considered. Physical activity
was self-reported by participants as part of a retrospect-
ive questionnaire at wave 2 follow-up (~age 83) [30].
Based on the methodology described by Hirvensalo and
colleagues [31], responses were scored on a six-item
scale according to increasing levels of physical activity.
Table 1 Consensus criteria for dementia case ascertainment
CONSENSUS CRITERIA FOR DEMENTIA CASE ASCERTAINMENT
PROBABLE DEMENTIA POSSIBLE DEMENTIA
ANY of the following
(without opposing evidence
from same/other source):
- dementia diagnosis on death
certificate (any part)
- dementia diagnosed on clinical
review (ICD-10/DSM-IV)
- dementia diagnosis in
electronic general medical
records (Trak)
- dementia diagnosis in
electronic psychiatric records
(PIMS)
- ICD-10 criteria for dementia
diagnosis met by data within
any existing records
ANY of the following
(without opposing evidence
from same/other source):
- recorded cognitive impairment
on death certificate
- cognitive impairment/decline
recorded in notes, but
incomplete evidence to meet
ICD-10 diagnostic criteria
- possibility of dementia
recorded in notes but no
formal diagnosis/incomplete
evidence to meet ICD-10 diag-
nostic criteria
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Responses predominantly related to leisure based activ-
ity: necessary movement, walking, walking/outdoor exer-
cises, exercising until sweating, exercising several times
per week, keep fit/heavy exercise. Participants indicated
their perceived level of physical activity at three age
ranges: 20–35, 40–55 and 60–75 years [30]. A lifetime
score was calculated by the sum of the three scores. The
physical effort required in a participant’s previous occu-
pation was assessed using a single item [Q21] from the
Job Content Questionnaire (JCQ) by Karasek [32, 33].
which was included, with permission, in the wave 2
questionnaire.
Age 11 IQ was derived from the results of the Moray
House Test (MHT) no. 12, undertaken by participants in
1932 [26]. Following correction for age at testing, the
cohort MHT scores were converted to IQ scores, with a
standardised sample mean score of 100 and SD of 15
[26]. To demonstrate how the cohort IQ compares with
the general population, we consider the raw MHT
scores: 34.5 (SD: 15.5) was the mean score for Scotland,
37.3 (SD: 14.8) for those in Edinburgh schools, and 46.4
(SD: 12.1) for those recruited to LBC1921 [25].
Statistical analyses
Statistical analysis was performed using IBM SPSS Statis-
tics software version 21. The primary outcome of the
study was the development of dementia. The analyses
were completed for an outcome of probable dementia,
with possible cases excluded. Univariate analysis was com-
pleted for each predictor variable, using either the Pearson
chi-square or t-test. At this stage, a p value of <0.05 was
used to demonstrate significant difference between those
who developed dementia and those who did not. Binary
logistic regression analysis was used to determine the risk
for dementia associated with each predictor variable. For
the purposes of logistic regression, the data for height and
age 11 IQ were standardised so that a unit increase repre-
sented one standard deviation increase on the original
scale. The following logistic regression models were com-
pleted using the ‘backward conditional’ function. The in-
put for model 1 included all variables. The analyses for
model 2 included all variables except lifetime physical ac-
tivity and physical activity in occupation, which were ex-
cluded since data were missing for around one-third of
participants (33.3 to 39.0% missing, with zero to 14.2%
missing for all other variables). The analyses for models 1
and 2 were repeated to include both probable and possible
dementia in the outcome, and the results are made avail-
able in the supplementary information.
Results
Five hundred fifty participants recruited to the LBC1921
attended the first wave of data collection. We excluded 9
participants with an MMSE score of less than 24 at
baseline, 2 participants missing MMSE results at base-
line, 2 participants who self-reported a diagnosis of de-
mentia at baseline and 10 participants with no follow-up
data available. The eligible cohort (n = 527) included
305 (57.9%) females and 425 (80.6%) were known to be
deceased by the 30th of June 2016. The mean age in
years at wave 1 was 79.1 years (SD: 0.6). APOE ɛ4 carrier
status was available for 521 participants (98.9%), with
139 (26.4%) recorded as carriers. The mean (standar-
dised) age 11 IQ score was 100.1 (SD: 14.8), calculated
from the 473 scores available (89.8% of the eligible co-
hort). The mean MMSE score for the eligible cohort was
28.3 (SD: 1.5). Descriptive statistics for those eligible for
inclusion, and those excluded are shown in Table 2.
One hundred twenty nine participants were found to
have evidence of cognitive impairment or dementia in
their records. A consensus diagnosis of probable
dementia was agreed for 110 participants (38 probable
Alzheimer disease, 25 probable vascular dementia, 9
probable mixed-type dementia, 1 probable progressive
supra-nuclear palsy, 6 possible vascular dementia, 1
possible dementia in Parkinson’s disease, and 30 of
unknown subtype) and a diagnosis of possible dementia
was determined for 7 participants (1 possible vascular
dementia, 6 unknown subtype). The remaining 12 cases
Table 2 Descriptive statistics for those included & excluded
from the study
Eligible cohort
participants
(n = 527)
Participants excluded
from study
(n = 23)
Deceased
Living 102 (19.4%) 11 (47.8%)
Deceased 425 (80.6%) 12 (52.2%)
Sex
Male 222 (42.1%) 12 (52.2%)
Female 305 (57.9%) 11 (47.8%)
Age at wave 1
Mean age in years 79.1 (SD: 0.6) 79.2 (SD: 0.5)
APOE ɛ4 carrier status
Carrier 139 (26.4%) 7 (30.4%)
Not carrier 382 (72.5%) 15 (65.2%)
Data missing 6 (1.1%) 1 (4.3%)
Age 11 IQ
Data available 473 (89.8%) 20 (87.0%)
Data missing 54 (10.2%) 3 (14.3%)
Mean age 11 IQ 100.1 (SD: 14.8) 97.8 (SD: 19.6)
MMSE
Data available 527 (100%) 21 (91.3%)
Data missing - 2 (8.7%)
Mean MMSE 28.3 (SD: 1.5) 25.2 (SD: 3.3)
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considered had either insufficient information for
diagnosis or evidence contradictory to a diagnosis of
dementia (for example, the evidence supports a diagno-
sis of delirium rather than dementia). Figure 1 illustrates
the number of probable cases ascertained by each data
source, or combination of data sources. Almost two
thirds of cases of probable dementia (63.6%) were deter-
mined based on a single source of information with the
largest proportion of these single source diagnoses being
based on death certificate data (Fig. 1).
All 7 cases of possible dementia were identified based
on evidence from a single source (death certificate or
electronic medical record). Of the 12 cases that did not
meet the criteria for probable or possible dementia, 9
were determined based on a single data source, whilst
the remaining 3 used two sources. The sources were as
follows: 9 used evidence from the electronic medical re-
cords only, 1 used evidence from both the electronic
medical records and the electronic psychiatric records
and 2 used evidence from the electronic medical records
and from clinical review.
Univariate analysis demonstrated significant differ-
ences between the group with probable dementia and
the group without dementia for the following variables:
positive APOE ɛ4 carrier status (p < 0.001), lower BMI
at age 79 (p = 0.026) and current smoking status at age
79 (p = 0.039) (Table 3).
Following the exclusion of possible cases of dementia
(n = 7), n = 520 participants were included in the logistic
regression analyses, of which n = 110 had developed
probable dementia. The results for these analyses are
shown in Table 4. In both models the presence of an
APOE ɛ4 allele increased the risk of dementia (model 2
OR: 2.37, 95% CI: 1.37, 4.07). A history of hypertension
was associated with a decreased risk for dementia in
both models (model 2 OR: 0.55, 95% CI: 0.32, 0.93).
Increased height was associated with a decrease in risk
for incident dementia in model 2 (model 2 OR: 0.73,
95% CI: 0.56, 0.96) and the same relationship
approached significance in model 1 (model 1 OR: 0.71,
95% CI: 0.49, 1.01). A higher lifetime leisure-based phys-
ical activity score was associated with an increased risk
of dementia in model 1 (OR: 1.14, 95% CI: 1.02, 1.28).
Although current smoking was included in both models,
the relationship with dementia did not reach signifi-
cance. Age did not demonstrate an effect in any model,
as might be expected in this narrow-age cohort.
To investigate the relationship with physical activity fur-
ther, analysis for a third model was completed in which
three individual age groups scores (20–35, 40–55, 60–
75 years) replaced the lifetime physical activity score. All
other variables were also included. Increased physical
activity at age 20–35 years was significantly associated with
incident dementia (OR: 1.35, 95% CI: 1.06, 1.73). The re-
sults of this model are shown in Additional file 2: Table S2.
Results for logistic regression analyses (models 1 and 2),
repeated with possible cases included in the outcome, can
be seen in Additional file 3: Table S3.
Validation study
In order to validate our case ascertainment method
using existing data sources, we completed a validation
Fig. 1 Number of probable dementia cases ascertained, by data source
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study comparing diagnoses extracted from existing data
with diagnoses made on clinical review. Clinical reviews
were performed for 26 participants. Of the 24 who were
diagnosed as having dementia on clinical review, 23 had
a diagnosis of dementia in at least one source of existing
data. This would suggest that we would miss 4% of cases
using existing data alone. Two participants seen for
clinical review were not diagnosed as having dementia,
Table 3 Univariate analyses: comparisons between groups with and without probable dementia
Variable No dementia
(n = 410)
Probable dementia
(n = 110)
Group comparison
p value (chi-square or t-test)
Age at wave 1 n = 410 n = 110
-mean age in years (SD) 79.1 (0.6) 79.0 (0.6) 0.610
Sex n = 410 n = 110
-% female 56.6 62.7 0.247
APOE ɛ4 carrier statusa n = 404 n = 110
-% carrier APOE ɛ4 22.5 40.9 <0.001
Age 11 IQ (standardised) n = 365 n = 102
-mean score (SD) 100.0 (14.5) 100.1 (16.1) 0.948
Teeth n = 410 n = 110
-mean number of teeth (SD) 9.2 (9.4) 9.6 (8.9) 0.706
Height n = 409 n = 107
-mean height in cm (SD) 163.6 (9.4) 162.1 (9.2) 0.144
Formal education n = 409 n = 109
-mean number of years (SD) 10.9 (2.4) 11.0 (2.7) 0.732
History of diabetes n = 410 n = 110
-% positive history 5.4 4.5 0.731
HbA1c n = 356 n = 98
-mean HbA1c (SD) 5.7 (0.8) 5.7 (0.5) 0.703
History of hypertension n = 406 n = 109
-% positive history 42.1 34.9 0.171
Systolic blood pressure n = 408 n = 109
-mean BP in mmHg (SD) 168.9 (27.3) 166.0 (24.8) 0.315
Diastolic blood pressure n = 408 n = 109
-mean BP in mmHg (SD) 83.1 (13.2) 81.8 (12.3) 0.352
Statin use n = 347 n = 99
-% positive history 7.5 11.1 0.250
Total serum cholesterol n = 401 n = 105
-mean (SD) 5.7 (1.1) 5.6 (1.1) 0.891
Depression (HADS) n = 409 n = 109
-mean depression score (SD) 3.5 (2.3) 3.5 (2.4) 0.966
BMI n = 409 n = 107
-mean kg/m2 (SD) 26.4 (4.2) 25.4 (4.0) 0.026
Smoking status n = 410 n = 109
-% current smoker 8.5 2.8 0.039
Lifetime physical activity n = 273 n = 74
-mean total lifetime score (SD) 8.7 (3.1) 9.5 (3.0) 0.058
Physical effort required in occupation n = 248 n = 69
-mean score (SD) 2.1 (0.8) 2.3 (0.8) 0.065
aOne or more alleles
Italicized results demonstrate significance of p<0.05
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but both had a diagnosis of dementia in the electronic
medical records. This discrepancy might reflect the use of
different diagnostic criteria, or the use of clinical judge-
ment in clinical practice, particularly where evidence is
ambiguous. Despite this discrepancy, our method would
identify dementia in 88% of cases, with 4% being false
negatives and 8% being false positives. Of the 17 cases
identified as Alzheimer’s disease (AD) on clinical review,
14 (82%) had AD listed as a diagnosis within at least one
data source. Of the 14 cases, 5 (36%) also had a different
subtype diagnosis recorded in existing data, 7 (50%) also
had dementia of an unspecified subtype recorded, while 2
(14%) cases listed only AD. Of the 2 cases identified as
vascular dementia on clinical assessment, 1 had vascular
dementia listed as a diagnosis within the existing data. Of
the 3 cases identified as mixed Alzheimer’s and vascular
dementia on clinical assessment 1 had a diagnosis of
mixed dementia in the existing data. These findings dem-
onstrate the usefulness of accessing records to find
evidence that will support a subtype diagnosis based on
recognised criteria. Our finding that overall dementia
diagnoses were confirmed in 88% of cases is comparable,
if not better than, validation procedures performed for
other existing data sources or methodologies.
Discussion
This study found that 21.2% of eligible, initially cognitively
normal participants from the LBC1921 developed demen-
tia from age 79 to 95 years. At the time of this study, 420
of 520 eligible participants had died, including 89 who had
died with dementia. A total of 21 participants with
dementia were alive at age 95. Our analyses indicated that
the presence of an APOE ɛ4 allele and greater lifetime
leisure-based physical activity increased the risk for
dementia. A history of hypertension and increased height
were found to reduce the risk for dementia.
The results of this study reinforce the importance of
the APOE ɛ4 allele as a risk factor for the development
of dementia [34, 35]. A number of studies have
suggested a decline in the importance of APOE ɛ4 as a
risk factor for dementia with advancing age [34, 36].
Somewhat to the contrary, our study has determined
that APOE ɛ4 continues to be a significant risk factor for
incident dementia from age 79 to 95.
Our results also indicated that a history of hyperten-
sion by age 79 was associated with a reduction in risk
for dementia. This result supports the findings of previ-
ous studies that have demonstrated that the association
of hypertension with dementia changes towards later life
[37]. We might hypothesize that persons surviving and
remaining dementia-free at the ninth decade of life, are
no longer subject to any increased risk as a result of vas-
cular factors such as hypertension. In simple terms, such
risk factors have been used up and those with hyperten-
sion who were at the highest risk for dementia are more
likely to have died from hypertension-related diseases
prior to the onset of dementia. As a result, we might ex-
pect a paradoxical effect, much like that seen in this
study. This hypothesis is supported by the direction of
relationship for physical activity. Previous studies have
hypothesized that a reduction in blood pressure is a con-
sequence of the development of dementia and, although
this mechanism is not fully understood, several pro-
cesses have been proposed [37, 38]. Blood pressure may
decline in early dementia due to the direct effect of
neurodegeneration at the brainstem and hypothalamic
nuclei- where arterial pressure is regulated- or it may be
related to systemic changes such as weight loss, or any
disease effecting the ability of the cardiovascular system
to maintain perfusion pressures throughout the body
[38]. Another possible explanation for the reduced risk
is the potentially protective effect of antihypertensive
agents, particularly as it is reported that antihypertensive
use in hypertension is higher in older age [39–42].
The findings relating to physical activity were more
unexpected with higher levels of overall leisure activity
throughout adulthood being linked with an increased
risk of developing dementia. As a consequence of
missing data, the findings relating to physical activity
were obtained for a smaller sample size and we must
therefore be cautious in drawing inferences from these
findings, particularly as they contradict studies that have
previously indicated a link between midlife inactivity and
dementia [11, 13]. The discrepancy between our findings
and those of previous studies may be related to the
method of data collection for these variables. Self-
reporting physical activity levels throughout life at 79 years
is likely to be subject to recall bias and variability between
participants.
In this cohort, one standard deviation increase in
height corresponded to 9.3 cm which was associated
with an approximately 27% reduction in odds of possible
Table 4 Logistic regression results
Odds ratios (95% CI) for probable dementia
Model 1 (n = 234) Model 2 (n = 377)
APOE ɛ4 2.15 (1.04,4.42) 2.37 (1.37,4.07)
Height (z score) 0.71 (0.49, 1.01) 0.73 (0.56, 0.96)
Hypertension 0.47 (0.23,0.98) 0.55 (0.32,0.93)
Current smoking 0.18 (0.02, 1.41) 0.25 (0.06, 1.09)
Lifetime physical activity 1.14 (1.02,1.28) -
The variables entered into the analyses for each model were as follows:
Model 1- age, sex, APOE ɛ4 carrier status, age 11 IQ (z score), number of teeth,
height (z score), years in education, history of diabetes, HbA1c, history of
hypertension, systolic blood pressure, diastolic blood pressure, cholesterol, use
of statins, HADS depression score, BMI, smoking status, physical activity in
occupation, lifetime physical activity (‘backward conditional’ method);
Model 2- as model 1, but physical activity in occupation and lifetime physical
activity excluded (‘backward conditional’ method)
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or probable dementia (OR: 0.73, 95% CI: 0.56, 0.96). Our
results are supported by the finding of a 2014 individual
participant meta-analysis, that increasing height was
related to a lower rates of death from dementia [43]. As
concluded by the authors, since height is regarded as a
marker of factors in early life, it may be these that are
related to risk of dementia [43]. Like APOE ɛ4, we have
demonstrated that decreased height continues to be a
significant risk factor for dementia in oldest age. By
demonstrating that certain recognised dementia risk
factors are unchanged in oldest age, we can be more
confident in our findings that the risk associated with
other factors is changed in oldest age.
Contrary to much of the existing literature, no other
factor considered in this study was found to be associ-
ated with dementia. We should consider however, that
the prevalence of some conditions, including diabetes
and depression, in our cohort was low and as a result,
we were unlikely to detect anything except large effects,
higher than those estimated by meta-analyses. [6, 9].
Power calculations determined that with binary logistic
regression, setting alpha = 0.05 and the group sizes fixed
at n = 410 (participants without dementia) and n = 110
(participants with dementia) with a base proportion of
5.4% (as for diabetes prevalence) in the n = 410, a mini-
mum prevalence of 14.1% would be required in the
n = 110 to detect a statistical difference with 80.0%
power. Further investigation using case-control studies
or much larger cohort studies are therefore required.
Moreover, given n = 110 people with dementia, the
number of participants with each subtype of dementia
was too few for analysis by individual subtype: combin-
ing cases of different aetiology may have affected the
analysis. As previously noted, some of the data collected
relied on recollection by the participant and was there-
fore subject to potential variability in reporting. The
associations between our variables may also have af-
fected our analyses. We attempted to minimise this as
far as possible, but such bias could not be eliminated
without excluding important variables. By examining
many different possible predictors for dementia, in more
than one model, there is also the potential for false posi-
tive findings. We limited the number of models in our
analyses to two to reduce the chance of such false find-
ings insofar as possible. A valuable strength of the study
cohort is the presence of an intelligence test score from
age 11 [16, 18, 21]. Each participant also underwent
careful background assessment and thorough follow-up,
providing a wealth of longitudinal data for the assess-
ment of modifiable risk factors. The LBC1921 is a
narrow-age cohort comprising ethnically, geographically
and culturally homogenous participants, which means
that we can rule out a number of potential confounding
effects. Follow-up data were available for a satisfactory
proportion of the original cohort to allow for analyses. The
cohort demographics for those excluded from the analyses
were similar to those included and it can therefore be as-
sumed that the eligible cohort was a successful representa-
tion of the whole cohort. With a mean baseline MMSE of
28.1 (SD: 1.7) for those participants who subsequently de-
veloped dementia, we can be confident that we have identi-
fied truly incident, as opposed to prevalent, cases.
To assess the effectiveness of our dementia detection
methodology, we sought to compare the incidence rate
found against the rates determined by previous studies.
Without knowing the age at diagnosis for a high
proportion of dementia cases, the expected overall
incidence over the study period had to be estimated (see
Additional file 4). Had all cases of dementia been ascer-
tained, we would have expected approximately 166 cases
(see Additional file 5: Table S4). The 110 cases of demen-
tia detected in this study therefore equates to 66.2% of the
estimated number of cases arising over the same time
period. This proportion is fairly consistent with a 2012
study of dementia diagnosis rates, which found that,
within Lothian (the Health Board where the LBC1921 is
resident), 68.3% of the expected cases of dementia had
received a diagnosis [44]. We also sought to establish
whether cases identified as possible dementia would be
confirmed with additional follow-up. Of the 7 possible de-
mentia cases, 5 were deceased at the time of the consen-
sus meeting and no further follow-up could be completed.
Electronic hospital records for the 2 other cases were
accessed on 10th January 2017 and both contained evi-
dence from that confirmed a formal diagnosis of demen-
tia. It should be noted that neither case was seen for
clinical review by ourselves and we did not therefore influ-
ence the diagnosis having been made.
This study has demonstrated the benefits of using mul-
tiple data sources for ascertainment. Our study returned
the greatest number of cases from death certificates,
which identified 68.2% of all cases of probable dementia,
and 84.3% of all deceased participants with probable
dementia. This finding would be in line with a previous
Scottish study that found 71.5% of patients who die with
dementia have the diagnosis on their death certificate [45].
Death certificates as a source of data benefit from their
availability, but it is clear that the potential for missed
cases remains. Many published UK studies utilising
existing data for dementia ascertainment use only a single
data source [46, 47]. As is the case with any dementia
ascertainment procedure, the emphasis must be on
achieving the most accurate representation of dementia
incidence or prevalence within the population. Where
possible, we would recommend that future studies con-
sider inconsistencies between sources on a case-by-case
basis. If there is reliable and consistent evidence in one
source, the absence of a diagnosis in another source
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should not be assumed to equate to an absence of the dis-
ease. Where there is contradictory evidence, of similar
weighting, from two or more sources, external evidence
can be sought to clarify the diagnosis. This may take the
form of a clinical review. Where no external evidence is
available or possible, cases with contradictory evidence
should be classified as possible cases and excluded from
the analyses due to the risk of misclassification. Using
existing data offers savings in terms of researcher and par-
ticipant time and the associated financial costs. This
method also allows for large population studies, where
clinical diagnostic work-up is not feasible due to scale.
Conclusions
In summary, the results of this study suggest that the
presence of an APOE ɛ4 allele is a risk factor for incident
dementia from age 79–95. A previous diagnosis of
hypertension and increasing height were found to reduce
the risk of incident dementia in the same age group.
Increased leisure-based physical activity in adulthood
was found to increase the risk for incident dementia, but
including this variable in the analyses reduced the study
sample size and we must therefore be cautious in draw-
ing inferences from this finding, particularly as it contra-
dicts previous studies. Our findings would support the
hypothesis that the risk profile for dementia alters with
age, however, further evidence would be required before
the risk profile for the ninth decade of life and beyond
could be accurately described.
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